Back to
Mariner, LLC
XLO
7 quarters
Position history for
Mariner, LLC's holdings in XILIO THERAPEUTICS INC
No. Mariner exited its XLO (Xilio Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 25,000 shares worth $16,005. Mariner first reported XLO in Q3 2024 and held it in 6 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$19,942
Total Shares Change
-25,317
Quarter-by-Quarter History